Press release

Ralf Thomas elected Chairman of the Supervisory Board of Siemens Healthineers AG

Published on November 28, 2019

On November 26, 2019, the Supervisory Board of Siemens Healthineers AG unanimously elected Ralf Thomas, 58, as its new Chairman, effective December 1, 2019. Ralf Thomas will succeed Michael Sen, 51, who resigned from his position as Chairman of the Supervisory Board, effective the close of November 30, 2019. Michael Sen is the co-CEO of Siemens’ Gas and Power Operating Company and the designated CEO of Siemens Energy AG, which is to become a publicly listed company in September 2020.

“I wish to thank the Supervisory Board for the trust they have placed in me, and I am looking forward to this interesting new challenge. I especially want to thank Michael Sen for his tremendous commitment to Siemens Healthineers. He has been instrumental in developing the medical technology business of Siemens AG for many years – first as CFO and ultimately as Supervisory Board Chairman – and he particularly deserves a great deal of credit for his work on the IPO of Siemens Healthineers. Siemens Healthineers AG generates significant value for its shareholders and therefore for Siemens AG, too. With the second phase of its medium-term strategy, Strategy 2025, which has just begun, the company is further expanding its technology leadership and entering attractive fields of business in adjacent markets,” said Thomas after his election as Supervisory Board Chairman.

"Congratulations to Ralf Thomas for being elected the new Chairman of the Supervisory Board of Siemens Healthineers AG. Following the IPO, Siemens Healthineers has successfully completed the first phase of its Strategy 2025. The latest business figures and the development in the share price underline that the company has reached a higher level of performance and is making excellent progress. This is a good time to hand over responsibility as Chairman of the Supervisory Board of Siemens Healthineers. As the future CEO of Siemens Energy, I am now putting all my strength into the upcoming spin-off and the successful future of that exciting company," said Michael Sen, outgoing Chairman of the Supervisory Board of Siemens Healthineers AG.

Ralf Thomas has been the CFO of Siemens AG since 2013. In addition, he has been a member of the Supervisory Board of Siemens Healthineers AG and the Chairman of its Audit Committee since March 2018. The medical technology company listed shares on the Frankfurt Stock Exchange on March 16, 2018. Siemens AG holds an 85 percent equity interest in Siemens Healthineers AG.

Link to download press picture of Ralf Thomas
Link to download press picture of Michael Sen

Siemens Healthineers 2021 DE

Siemens Healthineers AG (gelistet in Frankfurt a.M. unter SHL) hat den Anspruch, das Gesundheitswesen der Zukunft zu gestalten. Als eines der führenden Unternehmen der Medizintechnik mit Hauptsitz in Erlangen unterstützt es mittels seiner Regionalgesellschaften Gesundheitsversorger weltweit dabei, auf ihrem Weg hin zu dem Ausbau der Präzisionsmedizin, der Neugestaltung der Gesundheitsversorgung, der Verbesserung der Patientenerfahrung und der Digitalisierung des Gesundheitswesens mehr zu erreichen. Siemens Healthineers entwickelt sein Produkt- und Dienstleistungsportfolio kontinuierlich weiter, mit KI-gestützten Anwendungen und digitalen Angeboten, die in der nächsten Generation der Medizintechnik eine immer wichtigere Rolle spielen. Diese neuen Anwendungen werden das Unternehmen in der In-vitro-Diagnostik, der bildgestützten Therapie, der In-vivo-Diagnostik und der innovativen Krebsbehandlung weiter stärken. Siemens Healthineers bietet auch eine Reihe von Dienstleistungen und Lösungen an, um die Fähigkeit der Gesundheitsdienstleister zu verbessern, Patienten eine qualitativ hochwertige und effiziente Versorgung zu bieten. Im Geschäftsjahr 2020, das am 30. September 2020 endete, erzielte Siemens Healthineers ein Umsatzvolumen von 14,5 Milliarden Euro und ein bereinigtes EBIT von 2,2 Milliarden Euro. Nach der Übernahme von Varian Medical Systems, Inc. hat das Unternehmen weltweit rund 66.000 Beschäftigte. Weitere Informationen finden Sie unter www.siemens-healthineers.com.